Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011453 |
---|---|
Receipt number | R000013409 |
Scientific Title | Prospective study of chemoradiotherapy with gemcitabine and S-1 for borderline resectable or unresectable pancreatic cancer |
Date of disclosure of the study information | 2013/08/11 |
Last modified on | 2024/02/27 14:46:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/08/11 11:56:03 | ||
2 | Update | 2014/12/23 15:15:12 | UMIN ID1 |
|
3 | Update | 2015/04/28 20:03:39 | Last name of lead principal investigator Last name of lead principal investigator |
|
4 | Update | 2018/02/13 10:17:52 | Name of primary person or sponsor Organization |
|
5 | Update | 2020/02/15 11:32:04 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
6 | Update | 2020/02/15 11:33:12 | Recruitment status Date of IRB Last follow-up date |
|
7 | Update | 2024/02/27 14:46:23 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |